Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-function analysis of FLT3 ligand-FLT3 receptor interactions using a rapid functional screen

T J Graddis1, K Brasel, D Friend

  • 1Department of Protein Chemistry, Immunex Corporation, Seattle, Washington 98101, USA.

The Journal of Biological Chemistry
|July 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy.

Climacteric : the journal of the International Menopause Society·2023
Same author

Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design.

Pharmaceutical development and technology·2017
Same author

Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.

Journal of neurology, neurosurgery, and psychiatry·2016
Same author

Safety and efficacy of erythropoietin in traumatic brain injury patients: a pilot randomized trial.

Critical care research and practice·2010
Same author

Designing proteins that work using recombinant technologies.

Current pharmaceutical biotechnology·2002
Same author

Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.

Bioorganic & medicinal chemistry letters·2002

Researchers identified key mutations in FLT3 ligand (FLT3L) that enhance binding to its receptor. This structure-activity study advances understanding of hematopoietic cell stimulation and potential therapeutic development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematopoiesis

Background:

  • FMS-like tyrosine kinase 3 ligand (FLT3L) is crucial for stimulating primitive hematopoietic cells via FLT3 receptor (FLT3R) activation.
  • Understanding FLT3L-FLT3R interactions is vital for hematopoiesis research and therapeutic strategies.

Purpose of the Study:

  • To conduct a structure-activity study of human FLT3L to identify residues critical for FLT3 receptor binding.
  • To define the molecular basis of FLT3L's interaction with its receptor.

Main Methods:

  • Developed a high-throughput screening method using a FLT3R-Fc fusion protein to assess binding activity of mutagenized FLT3L.
  • Sequenced 59 clones from approximately 60,000 screened mutants.
  • Purified and analyzed 11 representative proteins for receptor affinity, specific activity, and physical properties.

Related Experiment Videos

Main Results:

  • Identified 31 single amino acid substitutions at 24 positions affecting FLT3L activity in receptor binding and cell proliferation.
  • Demonstrated a strong correlation between receptor affinity and bioactivity.
  • Showed that combining four beneficial mutations enhanced FLT3L receptor affinity.
  • Generated a 3D structural model of FLT3L, revealing that key binding residues cluster on a surface patch.
  • A mutation disrupting the predicted dimerization interface affected the FLT3L dimer structure.

Conclusions:

  • Pinpointed specific amino acid residues and mutations that modulate FLT3L-FLT3R binding and activity.
  • Provided insights into the structural determinants of FLT3L function and dimerization.
  • Established a foundation for rational design of FLT3L variants with improved properties for therapeutic applications.